50 External inter-laboratory reproducibility of PD-L1 IHC 22C3 pharmDx (SK006) for biliary tract adenocarcinoma at CPS ≥ 1 and CPS ≥ 10

• Siena Tabuena-Frolli,
• Deanna Moquin,
• Kristopher Kersch,
• Monika Polewski,
• Gregory Cherryholmes

Affiliations

Siena Tabuena-Frolli

Agilent Technologies, Inc., Carpinteria, CA, USA

Deanna Moquin

Agilent Technologies, Inc., Santa Barbara, CA, USA

Kristopher Kersch

Agilent Technologies, Inc., Carpinteria, CA, USA

Monika Polewski

Agilent Technologies, Inc., Carpinteria, CA, USA

Gregory Cherryholmes

1Agilent Technologies, Inc., Santa Clara, CA, USA